Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The activity of vancomycin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and non-hVISA isolates, using an in vitro pharmacodynamic model, was reduced in the presence of a high inoculum amount (10 8 CFU/ml). A high bacterial load of >10 5 CFU/ml persisted for all strains with doses up to 5 g every 12 h against high inoculum amounts. No change in the vancomycin MIC was detected in any isolate at a moderate inoculum amount (10 6 CFU/ml), and bactericidal activity occurred only against the non-hVISA isolate (time to 99% kill, 7.5 h; P = 0.001).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, in an in vitro PD model, the activity of vancomycin against heterogeneous vancomycin-intermediate S aureus (hVISA) and non-hVISA isolates was reduced in the presence of a high inoculum amount (10 8 colony-forming units per milliliter).75”
In the citing paper
“The effect of high bacterial densities on antimicrobial activity is called the inoculum effect in which certain groups of antimicrobials commonly used to treat IE such as β-lactams and glycopeptides (and, to a lesser extent, lipopeptides such as daptomycin) are less active against highly dense bacterial populations.[73][74][75]”
Citations
Cites
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Moise-Broder, P. A., Forrest, A., Birmingham, M. C., & Schentag, J. J. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00005 · Cited by 757
Howden, B. P., Ward, P. B., Charles, P. G. P., Korman, T. M., Fuller, A., Cros, P. D., Grabsch, E. A., Roberts, S. A., Robson, J., Read, K., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381202 · Cited by 484
Charles, P. G. P., Ward, P. B., Johnson, P. D. R., Howden, B. P., & Grayson, M. L. (2004) · Clinical Infectious Diseases · doi:10.1086/381093 · Cited by 384
LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4665-4672.2004 · Cited by 284
Self-citationWootton, M., MacGowan, A. P., Walsh, T. R., & Howe, R. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01508-06 · Cited by 122
Maor, Y., Rahav, G., Belausov, N., Ben-David, D., Smollan, G., & Keller, N. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01262-06 · Cited by 75
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationHowden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O'Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Warren, S. J. C., Gao, W., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01485-12 · Cited by 224
Bae, I., Federspiel, J. J., Miró, J. M., Woods, C. W., Park, L., Rybak, M. J., Rude, T. H., Bradley, S., Bukovski, S., de la Maria, C. G., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/606027 · Cited by 122
Self-citationUse of vancomycin pharmacokinetic–pharmacodynamic properties in the treatment of MRSA infections
Giuliano, C. A., Haase, K. K., & Hall, R. G. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.123 · Cited by 91
Casapao, A. M., Leonard, S. N., Davis, S. L., Lodise, T. P., Patel, N., Goff, D. A., LaPlante, K. L., Potoski, B. A., & Rybak, M. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00380-13 · Cited by 85
Self-citationAbubakar, H., Rashed, A., Subahi, A. E., Yassin, A., Shokr, M., & Elder, M. D. (2017) · Case Reports in Cardiology · doi:10.1155/2017/1923505 · Cited by 82
Gomes, D. M., Ward, K. E., & LaPlante, K. L. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1577 · Cited by 65
Sader, H. S., Jones, R. N., Rossi, K. L., & Rybak, M. J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp319 · Cited by 61
Self-citationEl catéter periférico: el gran olvidado de la infección nosocomial
Capdevila, J. A. (2013) · Revista española de quimioterapia. Suplemento · Cited by 57
Leonard, S. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042103 · Cited by 53
Self-citationYadav, R., Bulitta, J. B., Nation, R. L., & Landersdorfer, C. B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-16 · Cited by 49
Current and novel antibiotics against resistant Gram-positive bacteria
Pérez, F., Salata, R. A., & Bonomo, R. A. (2008) · Infection and Drug Resistance · doi:10.2147/idr.s3545 · Cited by 40
Zhanel, G. G., Voth, D., Nichol, K. A., Karlowsky, J. A., Noreddin, A. M., & Hoban, D. J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp176 · Cited by 33
Thiagaraj, A. K., Malviya, M., Htun, W. W., Telila, T. A., Lerner, S. A., Elder, M. D., & SCHREIBER, T. L. (2017) · Future Cardiology · doi:10.2217/fca-2016-0076 · Cited by 31
Rose, W. E., Knier, R., & Hutson, P. R. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq292 · Cited by 30
Self-citationJean, S., Lee, W., Yu, K.-W., Liao, C., Hsu, C.-W., Chang, F.-Y., Ko, W., Chen, R., Wu, J.-J., Chen, Y., et al. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.12.008 · Cited by 28
Leonard, S. N., Szeto, Y. G., Zolotarev, M., & Grigoryan, I. V. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.007 · Cited by 27
Self-citationDilworth, T. J., Leonard, S. N., Vilay, A. M., & Mercier, R.-C. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.06.027 · Cited by 26
Self-citationLenhard, J. R., Brown, T., Rybak, M. J., Meaney, C. J., Norgard, N. B., Bulman, Z. P., Brazeau, D. A., Gill, S. R., & Tsuji, B. T. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02657-15 · Cited by 25
Self-citationBroussou, D. C., Toutain, P., Woehrlé, F., Garch, F. E., Bousquet‐mélou, A., & Ferran, A. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211214 · Cited by 25
Vancomycin and maltodextrin affect structure and activity of Staphylococcus aureus biofilms
Kiamco, M. M., Atci, E., Khan, Q. F., Mohamed, A. H., Renslow, R. S., Abu‐Lail, N. I., Fransson, B. A., Call, D. R., & Beyenal, H. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25681 · Cited by 22
Zelenitsky, S. A., Alkurdi, N., Weber, Z., Ariano, R. E., & Zhanel, G. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01472-10 · Cited by 15
Pastells, C., Acosta, G., Pascual, N., Alberício, F., Royo, M., & Marco, M. ‐. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.07.049 · Cited by 8
Eichelberger, G. S., Kocab, M., Claudio, R. E., & Oller, K. L. (2022) · Cureus · doi:10.7759/cureus.25166 · Cited by 6
Haith, L. R., Patton, M. L., Guilday, R. E., Stair-Buchmann, M. E., Reigart, C. L., Young, C. L., & Ackerman, B. H. (2015) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000173 · Cited by 5
Unlocking the secret to Staphylococcus aureus survival in serum
Rose, W. E., & Sauer, J. (2026) · mSystems · doi:10.1128/msystems.01813-25 · Cited by 3
Self-citationAlsaeed, A., Wright, G. R., Deneer, H. G., Rubin, J. E., Sanche, S. E., & Blondeau, J. M. (2020) · Journal of Chemotherapy · doi:10.1080/1120009x.2020.1761191 · Cited by 2
Bhat, G. K., Kumari, J., Shenoy, S. M., Hegde, A. H., Mahabala, C., & Vidyalakshmi, K. (2017) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2017.v10i6.15993 · Cited by 2
Al-Hayali, O. Z., Marjani, M. F. A., & Maleki, A. (2024) · IRAQI JOURNAL OF AGRICULTURAL SCIENCES · doi:10.36103/fg0kcs57 · Cited by 2
Sivakumar, B. S., Chaudhuri, Vijaysegaran, & Chaudhuri (2012) · Orthopedic Research and Reviews · doi:10.2147/orr.s31222 · Cited by 1
Jehl, F., Schramm, F., Talagrand-Reboul, É., & Grillon, A. (2017) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2017.05.002 · Cited by 1
Khatib, R., Jose, J., Johnson, L. B., RIEDERER, K. M., & Shemes, S. P. (2015) · Journal of Microbiology and Infectious Diseases · doi:10.5799/jmid.123125 · Cited by 1
Al-Hayali, O. Z., Marjani, M. F. A., & Maleki, A. (2024) · IRAQI JOURNAL OF AGRICULTURAL SCIENCES · doi:10.36103/hwm37e61 · Cited by 1
Advances in the therapeutic monitoring of vancomycin concentrations
Nadrah, K. (2011) · Slovenian Medical Journal
Use of vancomycin pharmacokinetic- pharmacodynamic properties in the treatment of
Giuliano, C. A., Haase, K. K., & Hall, R. (2010)
Alkurdi, N. (2011) · Mspace (University of Manitoba)
Khakwani, M. S. K., Jalil, A., Hassan, Z., Khakwani, M., Anwar, Q., Rajab, F., & Sachdev, V. (2025) · Cureus · doi:10.7759/cureus.100022
Broussou, D. C. (2018) · theses.fr (ABES) · doi:10.70675/02a1c503zeaf8z4249z9939z984ac324edd4
Jalil, A., Rajab, F., Bandi, V. V., Bhatt, K., Kandel, A., Baral, B., Ravindran, A., & Haiy, A. U. (2026) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0000000000001616
Yang, D., Gu, M., Tang, X., He, L., (48506), J. Z., Wang, X., Hou, Y., Cui, Y., Li, C., Tian, J., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13473-6
Metadata
- Authors
- Rose, W. E., Leonard, S. N., Rossi, K. L., Kaatz, G. W., & Rybak, M. J.
- Affiliations
- Eugene Applebaum College of Pharmacy and Health Sciences (US)
- Wayne State University (US)
- Corresponding author
- Rybak, Michael J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-02
- Volume
- 53
- Issue
- 2
- Pages
- 805-807
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2630635
- OpenAlex
- W2083916456
- Semantic Scholar
- 1491ec88845fa8927d29156f603f174602f3a643
- Cited by
- 37
- References
- 7
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 8 · 2014: 1 · 2013: 3 · 2012: 2
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- vancomycin-intermediate Staphylococcus aureus, inoculum size, bacterial load, in vitro pharmacodynamic model, bactericidal activity, vancomycin MIC
- MeSH terms
- Anti-Bacterial Agents, Computer Simulation, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Colony Count, Microbial, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.